CD8A and neoplasm: Among these activities we find the ability to modulate the non-specific and innate immune functions of NK cells [182], CD4+ and CD8+ T cells, and/or cytokine production [183,184] inflammation [185], and apoptosis through multiple pathways [180,186] that have been shown to lead to anti-tumor properties in vivo [184].